Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target refers to specific genomic DNA sequences, primarily enhancers and promoters, characterized by composite Sox-Oct motifs and GC-rich Klf4-binding sites. These regulatory elements serve as the primary docking sites for the master transcription factors SOX2, OCT4 (POU5F1), and KLF4, which together govern the core transcriptional network of pluripotent stem cells [Boyer et al., 2005, Cell]. The Sox-Oct motif allows for the synergistic binding of SOX2 and OCT4, which is essential for the expression of genes like Nanog and Sox2 itself, maintaining the undifferentiated state of embryonic stem cells [Reményi et al., 2003, Genes & Dev]. Klf4 binds to adjacent GC-rich regions to stabilize this network and can also modulate genes involved in neurogenesis and cell cycle regulation [Wei et al., 2009, Stem Cells]. While these DNA sequences are not traditional protein targets, they are of significant interest in regenerative medicine for cellular reprogramming and in oncology, as many "stemness" genes are hijacked by cancer stem cells [Takahashi & Yamanaka, 2006, Cell]. Small molecules such as Mithramycin A can interact with these GC-rich sites to inhibit the binding of transcription factors, offering a potential therapeutic route to suppress oncogenic stemness [Remsing et al., 2003, JACS]. However, targeting these fundamental regulatory motifs poses significant challenges regarding specificity and the risk of inducing unintended epigenetic changes or tumorigenesis.
Competitive inhibition of transcription factor binding to specific DNA motifs
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Genomic DNA at Sox-Oct and Klf4 regulatory motifs (SOK-DNA).